This combination upregulated type I interferon response and MHC class I and PD-L1 on the tumour cell surface and increased PD-1 CD4+ and CD8+ T-cells [42], indicative of a possible response to immunotherapy. The gene discussed is CD8A; the disease is neoplasm.